Peptide vaccine as an adjuvant therapy for glypican‐3‐positive hepatocellular carcinoma induces peptide‐specific CTLs and improves long prognosis

There is no established postoperative adjuvant therapy for hepatocellular carcinoma (HCC), and improvement of patient prognosis has been limited. We conducted long‐term monitoring of patients within a phase II trial that targeted a cancer antigen, glypican‐3 (GPC3), specifically expressed in HCC. We...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Sci
Hoofdauteurs: Taniguchi, Masatake, Mizuno, Shoichi, Yoshikawa, Toshiaki, Fujinami, Norihiro, Sugimoto, Motokazu, Kobayashi, Shin, Takahashi, Shinichiro, Konishi, Masaru, Gotohda, Naoto, Nakatsura, Tetsuya
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2020
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7419030/
https://ncbi.nlm.nih.gov/pubmed/32449239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14497
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items